Implementation of Substance Use Treatment in Ambulatory Care

This Guide provides concrete strategies and actions for hospitals and health systems seeking to implement, strengthen and sustain telebehavioral health programs.

Provides guidance to addiction treatment clinicians and programs on the regulatory and general practice issues related to the use of telehealth during the COVID-19 national emergency.

This whitepaper examines telehealth risks utilizing the eight American Society for Health Care Risk Management (ASHRM) enterprise risk management (ERM) domains.

This Clinical Practice Guideline (CPG) provides an evidence-based framework for evaluating, treating, and managing the individual needs of patients with substance use disorders (SUD), including alcohol use disorder, in the VA and DoD. It is intended for use by all VA and DoD healthcare providers.

This guide provides considerations and strategies for clinicians and organizations implementing evidence-based practices. Approaches presented will assist clinicians, behavioral health organizations, primary care providers, insurers, and policy makers in understanding, selecting, and implementing evidence-based interventions that support adults with concurrent substance use and/or concurrent substance use disorders, including alcohol.

A final recommendation statement from the U.S. Preventive Services Task Force (USPSTF) on screening for unhealthy drug use.

This manual contains all the materials necessary for a counselor to conduct individual and group sessions using the Matrix Intensive Outpatient Treatment for People with Stimulant Use Disorders (IOP) approach.

This manual provides counselors with an overview of the Family Education component of the Matrix Intensive Outpatient Treatment for People with Stimulant Use Disorders (IOP) package and general guidelines for conducting sessions.

A Protocol using empirically-supported behavioral treatments for people with psychoactive stimulant use disorders. There are manuals for healthcare professionals who provide treatment services for individuals with psychoactive substance use disorder (PSUD) and for patients who are entering PSUD treatment.

This brief describes research documenting the added challenges stimulant use contributes to those who use opioids and patient-centered approaches for working with people who use stimulants that are enrolled in medication treatment for opioid use disorder.